Kathleen Simpson, M.D.  simpson_k@kids.wustl.edu

Profile picture
Assistant Professor of Pediatrics, Cardiology
Cardiac Transplant Program



  • BA, University of Missouri - Kansas City2006
  • MD, University of Missouri - Kansas City School of Medicine2006


  • Residency, Pediatrics, University of Missouri-Kansas City School of Medicine-Children's Mercy Hospitals and Clinics2006 - 2009
  • Fellowship, Pediatric Cardiology, Washington University in Saint Louis - St. Louis Children's Hospital2009 - 2012
  • Fellowship, Pediatric Heart Failure and Transplant, Washington University in Saint Louis - St. Louis Children's Hospital2012 - 2013

Licensure and Board Certification

  • 2006 - PresMO, Missouri State Medical License
  • 2009 - PresGeneral Pediatrics Board Certification
  • 2009 - PresPediatric Board Certification
  • 2012 - PresPediatric Cardiology Board Certification
  • 2012 - PresPediatric Cardiology Board Certification

Honors and Awards

  • Gold Humanism Honor Society Award2006 - 2006

Recent Publications view all (22)

Publication Co-Authors

  1. Moderate- severe primary graft dysfunction after pediatric heart transplantation Pediatr Transpl. 2019;Epub. PMID:30609166 
  2. Fontan-associated protein-losing enteropathy and post‒heart transplant outcomes: A multicenter study. J Heart Lung Transplant. 2018;Epub. PMID:30391195  
  3. Impact of routine surveillance biopsy intensity on the diagnosis of moderate to severe cellular rejection and survival after pediatric heart transplantation. Pediatr Transplant. 2018. PMID:29377465 
  4. Early stroke post-heart transplant is associated with decreased survival in children. J Heart Lung Transplant. 2018. PMID:29395751 
  5. End-stage renal disease after pediatric heart transplantation: a 25-year national cohort study J Heart Lung Transplant. 2017;S1053. PMID:29055603 
  6. Outcomes and Trends of Ventricular Assist Device Selection in Children with End-Stage Heart Failure ASAIO J. 2017;63(4):464-469. doi:10.1097  PMID:28009713 
  7. Impact of age on incidence and prevalence of moderate-to-severe cellular rejection detected by routine surveillance biopsy in pediatric heart transplantation J Heart Lung Transplant. 2017;36(4):451-456. PMID:27865735 
  8. Fontan patient survival after pediatric heart transplantation has improved in the current era Ann Thorac Surg. 2017;103(4):1315-1320. doi:27863728   PMID:27863728  
  9. Autoimmunity Against the Heart and Cardiac Myosin in Children With Myocarditis. J Card Fail. 2016;22(7):520-8. PMID:26941007 
  10. Improved survival after heart transplant for failed Fontan patients with preserved ventricular function. J Heart Lung Transplant. 2016. doi:10.1016/j.healun.2016.02.005  PMID:27068035 
  11. High Frequency of Detection by PCR of Viral Nucleic Acid in The Blood of Infants Presenting with Clinical Myocarditis. Pediatr Cardiol. 2016;37(2):399-404. PMCID:PMC4775434  PMID:26499513 
  12. Early Biventricular Assist Device Use in Children: A Single-Center Review of 31 Patients. ASAIO J. 2015;61(6):688-94. PMID:26186261 
  13. Continuous Flow Device Support in Children Using the HeartWare HVAD: 1,000 Days of Lessons Learned From a Single Center Experience. ASAIO J. 2015;61(5):569-73. PMID:25967955 
  14. Pediatric Quality of Life while Supported with a Ventricular Assist Device. Congenit Heart Dis. 2015;10(4):E189-96. doi:10.1111/chd.12260  PMID:25864509 
  15. Intravenous home inotropic use is safe in pediatric patients awaiting transplantation. Circ Heart Fail. 2015;8(1):64-70. doi:10.1161/CIRCHEARTFAILURE.114.001528  PMID:25472966 
  16. Children with myocarditis and new onset dilated cardiomyopathy have evidence of autoimmunity and viremia at presentation. Progress in Pediatric Cardiology. 2014;37(1):39-40. 
  17. Tissue Doppler septal Tei index indicates severity of illness in pediatric patients with congestive heart failure. Pediatr Cardiol. 2014;35(3):411-8. doi:10.1007/s00246-013-0794-1  PMCID:PMC3944049  PMID:24061276 
  18. Liver cirrhosis in Fontan patients does not affect 1-year post-heart transplant mortality or markers of liver function. J Heart Lung Transplant. 2014;33(2):170-7. doi:10.1016/j.healun.2013.10.033  PMCID:PMC3985609  PMID:24365764 
  19. Fontan-Associated Liver Disease: Reversible with Cardiac Transplantation, or "Past the Point of No Return"? ISHLT Links. 2013;5(5). 
  20. Failed Fontan heart transplant candidates with preserved vs impaired ventricular ejection: 2 distinct patient populations. J Heart Lung Transplant. 2012;31(5):545-7. doi:10.1016/j.healun.2012.02.003  PMID:22381208 
  21. Successful subxyphoid hybrid approach for placement of a Melody percutaneous pulmonary valve. Catheter Cardiovasc Interv. 2011;78(1):108-11. doi:10.1002/ccd.22930  PMID:21234917 
  22. Atrial tachyarrhythmias in neonatal enterovirus myocarditis. Pediatr Cardiol. 2009;30(6):827-30. doi:10.1007/s00246-009-9398-1  PMID:19294461 
Last updated: 08/29/2019
© 2022 by Washington University in St. Louis
One Brookings Drive, St. Louis, MO 63130